Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease

Background: Genetic factors have a well-known influence on Parkinson's disease (PD) susceptibility; however, no previous studies have investigated the influence of SNCA mutations on the natural history of PD using a prospective follow-up study. The aim of this study was to assess the risk facto...

Full description

Bibliographic Details
Main Authors: Ningdi Luo, Yuanyuan Li, Mengyue Niu, Liche Zhou, Mengsha Yao, Lin Zhu, Guanyu Ye, Wenyan Kang, Jun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnagi.2019.00110/full
_version_ 1818925587609157632
author Ningdi Luo
Yuanyuan Li
Mengyue Niu
Liche Zhou
Mengsha Yao
Lin Zhu
Guanyu Ye
Wenyan Kang
Wenyan Kang
Jun Liu
Jun Liu
author_facet Ningdi Luo
Yuanyuan Li
Mengyue Niu
Liche Zhou
Mengsha Yao
Lin Zhu
Guanyu Ye
Wenyan Kang
Wenyan Kang
Jun Liu
Jun Liu
author_sort Ningdi Luo
collection DOAJ
description Background: Genetic factors have a well-known influence on Parkinson's disease (PD) susceptibility; however, no previous studies have investigated the influence of SNCA mutations on the natural history of PD using a prospective follow-up study. The aim of this study was to assess the risk factors of variation of SNCA on the prognosis symptoms of PD patients.Methods: Fifty PD patients were recruited with 38 v-PSG confirmed PD+RBD patients, and the median follow-up period was 30 months. All patients underwent a comprehensive clinical evaluation at baseline and follow-up, and six SNPs of SNCA (rs356165, rs3857053, rs1045722, rs894278, rs356186, and rs356219) were analyzed. Cox proportional hazards regression models and Kaplan–Meier plot analysis were used to assess the associations between the SNCA variation and the primary and secondary progression outcomes.Results: Based on the clinical assessment, we found that hyposmia was substantially easier to aggravate. Regression analysis showed that patients with the T allele of rs1045722 and the G allele of rs356219 presented a 34 and 20% decreased risk of progression to the H-Y stage, respectively (p = 0.022; p = 0.005). While for rs894278, G allele patients showed a 47% decreased risk of olfactory dysfunction (p = 0.029). Further subgroup analysis showed that PD+RBD patients with rs356219/G exhibited a 30% and 20% decreased risk of progression on the H-Y stage and MoCA score (p = 0.038; p = 0.045).Conclusions: Our results indicated that genetic variation in SNCA may contribute to variability natural progression of PD and could possibly be used as a prognostic marker.
first_indexed 2024-12-20T02:43:36Z
format Article
id doaj.art-4b7f3fa558964e6c8aaa24770caedf61
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-20T02:43:36Z
publishDate 2019-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-4b7f3fa558964e6c8aaa24770caedf612022-12-21T19:56:15ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652019-05-011110.3389/fnagi.2019.00110450626Variants in the SNCA Locus Are Associated With the Progression of Parkinson's DiseaseNingdi Luo0Yuanyuan Li1Mengyue Niu2Liche Zhou3Mengsha Yao4Lin Zhu5Guanyu Ye6Wenyan Kang7Wenyan Kang8Jun Liu9Jun Liu10Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaRuijin Hospital North Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaDepartment of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, ChinaCAS Center for Excellence in Brain Science and Intelligence Technology, Shanghai, ChinaBackground: Genetic factors have a well-known influence on Parkinson's disease (PD) susceptibility; however, no previous studies have investigated the influence of SNCA mutations on the natural history of PD using a prospective follow-up study. The aim of this study was to assess the risk factors of variation of SNCA on the prognosis symptoms of PD patients.Methods: Fifty PD patients were recruited with 38 v-PSG confirmed PD+RBD patients, and the median follow-up period was 30 months. All patients underwent a comprehensive clinical evaluation at baseline and follow-up, and six SNPs of SNCA (rs356165, rs3857053, rs1045722, rs894278, rs356186, and rs356219) were analyzed. Cox proportional hazards regression models and Kaplan–Meier plot analysis were used to assess the associations between the SNCA variation and the primary and secondary progression outcomes.Results: Based on the clinical assessment, we found that hyposmia was substantially easier to aggravate. Regression analysis showed that patients with the T allele of rs1045722 and the G allele of rs356219 presented a 34 and 20% decreased risk of progression to the H-Y stage, respectively (p = 0.022; p = 0.005). While for rs894278, G allele patients showed a 47% decreased risk of olfactory dysfunction (p = 0.029). Further subgroup analysis showed that PD+RBD patients with rs356219/G exhibited a 30% and 20% decreased risk of progression on the H-Y stage and MoCA score (p = 0.038; p = 0.045).Conclusions: Our results indicated that genetic variation in SNCA may contribute to variability natural progression of PD and could possibly be used as a prognostic marker.https://www.frontiersin.org/article/10.3389/fnagi.2019.00110/fullParkinson's diseaseRBDSNCASNPdisease progression
spellingShingle Ningdi Luo
Yuanyuan Li
Mengyue Niu
Liche Zhou
Mengsha Yao
Lin Zhu
Guanyu Ye
Wenyan Kang
Wenyan Kang
Jun Liu
Jun Liu
Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
Frontiers in Aging Neuroscience
Parkinson's disease
RBD
SNCA
SNP
disease progression
title Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
title_full Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
title_fullStr Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
title_full_unstemmed Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
title_short Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
title_sort variants in the snca locus are associated with the progression of parkinson s disease
topic Parkinson's disease
RBD
SNCA
SNP
disease progression
url https://www.frontiersin.org/article/10.3389/fnagi.2019.00110/full
work_keys_str_mv AT ningdiluo variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT yuanyuanli variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT mengyueniu variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT lichezhou variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT mengshayao variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT linzhu variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT guanyuye variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT wenyankang variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT wenyankang variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT junliu variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease
AT junliu variantsinthesncalocusareassociatedwiththeprogressionofparkinsonsdisease